These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22110936)

  • 41. Opioid therapy in patients with chronic noncancer pain: diagnostic and clinical challenges.
    Cheatle MD; O'Brien CP
    Adv Psychosom Med; 2011; 30():61-91. PubMed ID: 21508626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An overview of abuse-deterrent opioids and recommendations for practical patient care.
    Adler JA; Mallick-Searle T
    J Multidiscip Healthc; 2018; 11():323-332. PubMed ID: 30026658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Strategies to prevent opioid misuse, abuse, and diversion that may also reduce the associated costs.
    Hahn KL
    Am Health Drug Benefits; 2011 Mar; 4(2):107-14. PubMed ID: 25126342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physicians' beliefs and likelihood of prescribing opioid tamper-resistant formulations for chronic noncancer pain patients.
    Turk DC; Dansie EJ; Wilson HD; Moskovitz B; Kim M
    Pain Med; 2014 Apr; 15(4):625-36. PubMed ID: 24612185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Multicomponent Intervention to Improve Primary Care Provider Adherence to Chronic Opioid Therapy Guidelines and Reduce Opioid Misuse: A Cluster Randomized Controlled Trial Protocol.
    Lasser KE; Shanahan C; Parker V; Beers D; Xuan Z; Heymann O; Lange A; Liebschutz JM
    J Subst Abuse Treat; 2016 Jan; 60():101-9. PubMed ID: 26256769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of prescription opioid abuse: the role of the dentist.
    Denisco RC; Kenna GA; O'Neil MG; Kulich RJ; Moore PA; Kane WT; Mehta NR; Hersh EV; Katz NP
    J Am Dent Assoc; 2011 Jul; 142(7):800-10. PubMed ID: 21719802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opioids Use and Abuse: Prescription Practice, Attitude, and Beliefs among Doctors of Karachi.
    Majid Z; Tanveer M; Ali Asghar S; Tahir F; Minhaj A; Khan HA; Sialvi T; Mahmood SH; Qadar LT; Imtiaz F
    Cureus; 2019 Jul; 11(7):e5253. PubMed ID: 31572638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prescription Opioid Misuse, Abuse, Morbidity, and Mortality: Balancing Effective Pain Management and Safety.
    Cheatle MD
    Pain Med; 2015 Oct; 16 Suppl 1():S3-8. PubMed ID: 26360931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increase your Confidence in Opioid Prescribing: Marketing Messages in Continuing Medical Education Activities on ER/LA Opioids.
    Goodwin B; Lim HD; Butler J; Paglia D; Dempsey MT; O Connor B; Fugh-Berman A
    Pain Physician; 2021 Aug; 24(5):E529-E538. PubMed ID: 34323440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse.
    Wiedemer NL; Harden PS; Arndt IO; Gallagher RM
    Pain Med; 2007; 8(7):573-84. PubMed ID: 17883742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?
    Chakravarthy K; Goel A; Jeha GM; Kaye AD; Christo PJ
    Curr Pain Headache Rep; 2021 Feb; 25(2):12. PubMed ID: 33598816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic pain: reducing costs through early implementation of adherence testing and recognition of opioid misuse.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):132-9. PubMed ID: 22104462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current status and evolving role of abuse-deterrent opioids in managing patients with chronic pain.
    Webster L; St Marie B; McCarberg B; Passik SD; Panchal SJ; Voth E
    J Opioid Manag; 2011; 7(3):235-45. PubMed ID: 21823554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pain Control in the Presence of Drug Addiction.
    Vadivelu N; Lumermann L; Zhu R; Kodumudi G; Elhassan AO; Kaye AD
    Curr Pain Headache Rep; 2016 May; 20(5):35. PubMed ID: 27068665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current and future development of extended-release, abuse-deterrent opioid formulations in the United States.
    Webster LR; Markman J; Cone EJ; Niebler G
    Postgrad Med; 2017 Jan; 129(1):102-110. PubMed ID: 27915497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dancing with Deterrents: Understanding the Role of Abuse-Deterrent Opioid Formulations and Naloxone in Managing Cancer Pain.
    Mitchell MT
    Oncologist; 2019 Dec; 24(12):1505-1509. PubMed ID: 31152083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risks and responsibilities in prescribing opioids for chronic noncancer pain, part 2: best practices.
    Cone EJ; DePriest AZ; Gordon A; Passik SD
    Postgrad Med; 2014 Nov; 126(7):129-38. PubMed ID: 25387221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opioid Screening Practices in the Cancer Pain Patient.
    Liebling D; Mehta N; Gulati A
    J Palliat Med; 2019 Jan; 22(1):10-17. PubMed ID: 30153080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of the Opioid Compliance Checklist to Monitor Chronic Pain Patients Receiving Opioid Therapy in Primary Care.
    Jamison RN; Martel MO; Huang CC; Jurcik D; Edwards RR
    J Pain; 2016 Apr; 17(4):414-23. PubMed ID: 26705974
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.